| 标题： | EVIDENCE-BASED CLINICAL PRACTICE GUIDELINE FOR THE TRANSFUSION OF BLOOD COMPONENTS IN THE PEDIATRIC AGE GROUPS |
| 版本： | 改编版 |
| 分类： | 标准指南 |
| 领域： | 综合 |
| 国家和地区： | 埃及 |
| 指南使用者： | o Healthcare professionals in primary, secondary, and tertiary care of neonatal and maternity services including physicians, nurses, pharmacists, laboratory technicians. Primary health care physicians and general practitioners Family medicine specialists Pediatricians Neonatologist Hematologists Nurses Blood bank specialist o Clinical Specialties Physicians (pediatricians, neonatologists, pediatric infectious diseases, microbiologists, and obstetricians), clinical pharmacists, nurses, laboratory technicians, and midwives. |
| 证据分级方法： | The description of the methodology for the production of this adapted CPG can be fulfilled by utilizing the ‘Adapted ADAPTE’ method. This CPG formal adaptation method includes three phases (setup, adaptation, and finalization), nine modules, and 24 steps with modifications in the steps and tools to suit the local general healthcare setting in Egypt. Overall, the steps of CPG adaptation includes the selection of the high-priority health topic, formulation of the CPG adaptation working group, identification of health questions using the PIPOH model, searching and selecting the source original CPGs with clear inclusion and exclusion criteria, quality assessment of included source CPGs by using the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument, assessment of the currency of the selected source CPGs, drafting of the adapted CPG, external review and consultation process, finalization of the adapted CPG with a set of implementation tools, declaration of conflicts of interests, and finally a plan for review and update. For further details on the specific modifications in steps and tools, refer to the article https://doi.org/10.1111/jep.12479]. |
| 制定单位： | Egyptian Pediatric Clinical Practice Guidelines Committee (EPG), Egypt. |
| 注册时间： | 2022-08-04 |
| 注册编号： | PREPARE-2022CN444 |
| 指南制订的目的： | 1) Provide an evidence-based document for the appropriate use of blood components. 2) Define indications, dosing, and administration of different blood components. 3) Safe transfusion practice including pre-transfusion testing, handling of blood component, and close monitoring of transfused patients. 4) Recommendations in special situations (multi-transfused subjects, massive transfusion, and the critically ill). |
最新注册
